Spathulenol
Based on 1 Customer Validation
Spathulenol is isolated from Aristolochia yunnanensis, and has antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities. Spathulenol shows a high antioxidant activity with an IC50 of 85.60 μg/mL in the DPPH system.
For research use only. We do not sell to patients.
- Purity: 99.20%
- CAS No.: 6750-60-3
- Formula: C15H24O
- Molecular Weight:220.35
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human A431 cells
Cytotoxicity against human A431 cells
|
[PMID: 1517737] |
| BC1 cell line | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human BC1 cells
Cytotoxicity against human BC1 cells
|
[PMID: 1517737] |
| BC1 cell line | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against human BC1 cells
Cytotoxicity against human BC1 cells
|
[PMID: 7931367] |
| Col2 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human Col2 cells
Cytotoxicity against human Col2 cells
|
[PMID: 1517737] |
| Col2 | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against human Col2 cells
Cytotoxicity against human Col2 cells
|
[PMID: 7931367] |
| HT-1080 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human HT1080 cells
Cytotoxicity against human HT1080 cells
|
[PMID: 1517737] |
| HT-1080 | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against human HT1080 cells
Cytotoxicity against human HT1080 cells
|
[PMID: 7931367] |
| KB | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 1517737] |
| KB | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 7931367] |
| KB-V1 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human vinblastine-resistant KBV1 cells
Cytotoxicity against human vinblastine-resistant KBV1 cells
|
[PMID: 1517737] |
| KB-V1 | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against human KBV1 cells
Cytotoxicity against human KBV1 cells
|
[PMID: 7931367] |
| LNCaP | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human LNCAP cells
Cytotoxicity against human LNCAP cells
|
[PMID: 1517737] |
| Lu1 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 1517737] |
| Lu1 | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 7931367] |
| P388 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 1517737] |
| P388 | ED50 |
>20 μg/mL
Compound: spathulenol
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 7931367] |
| SK-MEL-2 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human SK-MEL-2 cells
Cytotoxicity against human SK-MEL-2 cells
|
[PMID: 1517737] |
| SK-MEL-2 | ED50 |
6.3 μg/mL
Compound: spathulenol
|
Cytotoxicity against human SK-MEL-2 cells
Cytotoxicity against human SK-MEL-2 cells
|
[PMID: 7931367] |
| ZR-75-1 | ED50 |
>20 μg/mL
Compound: (+)-Spathulenol
|
Cytotoxicity against human ZR-75-1 cells
Cytotoxicity against human ZR-75-1 cells
|
[PMID: 1517737] |
Spathulenol exhibits a high antioxidant activity s in the DPPH and MDA system, exhibits significant DPPH free radical activity, with IC50 values of 85.60 μg/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 6750-60-3
-
Appearance Liquid (Density: 1.02±0.1 g/cm3)
-
Molecular Weight 220.35
-
Formula C15H24O
-
Color Colorless to light yellow
-
SMILES
O[C@@]([C@@]1([H])[C@@](C2(C)C)([H])[C@@]2([H])CC3)(C)CC[C@@]1([H])C3=C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 100 mg/mL (453.82 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (11.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (11.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (282 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.5382 mL | 22.6912 mL | 45.3823 mL | 113.4559 mL |
| 5 mM | 0.9076 mL | 4.5382 mL | 9.0765 mL | 22.6912 mL | |
| 10 mM | 0.4538 mL | 2.2691 mL | 4.5382 mL | 11.3456 mL | |
| 15 mM | 0.3025 mL | 1.5127 mL | 3.0255 mL | 7.5637 mL | |
| 20 mM | 0.2269 mL | 1.1346 mL | 2.2691 mL | 5.6728 mL | |
| 25 mM | 0.1815 mL | 0.9076 mL | 1.8153 mL | 4.5382 mL | |
| 30 mM | 0.1513 mL | 0.7564 mL | 1.5127 mL | 3.7819 mL | |
| 40 mM | 0.1135 mL | 0.5673 mL | 1.1346 mL | 2.8364 mL | |
| 50 mM | 0.0908 mL | 0.4538 mL | 0.9076 mL | 2.2691 mL | |
| 60 mM | 0.0756 mL | 0.3782 mL | 0.7564 mL | 1.8909 mL | |
| 80 mM | 0.0567 mL | 0.2836 mL | 0.5673 mL | 1.4182 mL | |
| 100 mM | 0.0454 mL | 0.2269 mL | 0.4538 mL | 1.1346 mL |